“High-Cost Drugs”

70 result(s)
Public Policy
RxSavingsPlus
RxSavingsPlus Provides Savings for Members without Pharmacy Benefits More
Video
Cost Management
Reducing Wasteful Spend on High-Cost, Low-Value Drugs
CVS Health’s Hyperinflation Strategy Helps Clients Reduce Unnecessary Drug Spend More
Briefing
Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and Approval Timelines
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines More
Briefing
Drug Pipeline
Treatment Options Expand in Robust Gene Therapy Pipeline
New Gene Therapies for Sickle Cell Disease, Hemophilia on the Horizon More
Briefing
Drug Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline More
Briefing
Drug Pipeline
New Migraine Drugs Near Approval
... More
Briefing
Cost Management
2022 CVS Caremark Formulary Updates
2022 CVS Caremark Formulary Updates Deliver Exceptional Value and Cost Management More
Briefing
Cost Management
Assessing New-to-Market Biologics and Biosimilars
CVS Health offers strategies for addressing new-to-market products to ensure access to clinically appropriate insulin or other medications. More
Commentary
Drug Pipeline
Gene Therapies in the Pipeline Highlight a Variety of Conditions and Anticipated Treatments
The gene therapy pipeline report highlights what payors can expect for a variety of conditions. More
Briefing
Drug Pipeline
Biosimilars Help Support Members, Payors with Affordable Options
Biosimilars help to increase market competition. Balancing the use of biosimilars and biologics with strategic formulary decisions deliver lower costs. More
Briefing